About Us
Transforming Cancer Care

Advancements in Lung Cancer Treatment Provide Hope for Patients

Nov 7, 2024

Receiving a lung cancer diagnosis can be overwhelming, and you may have questions about your options and what comes next. Fortunately, there is hope through the many recent advances made in lung cancer treatment.

The number of therapies approved to treat lung cancer has dramatically increased in recent years. SCRI Oncology Paratners is proud to continue to offer new options as the research evolves.

Immunotherapy Treatments Help Immune System Target Lung Cancer Cells

Immunotherapy drugs leverage your existing immune system to fight your lung cancer. These treatments can either boost your immune system or change the way your immune system works to target lung cancer cells.

Cancer cells can hide from your immune system, causing your natural defense system to remain inactive. Well-known immunotherapy drugs include KEYTRUDA® and OPDIVO®, both of which work by activating your immune system so it can recognize and identify cancer cells that are hiding. In recent years, these drugs have been approved to treat several types of lung cancer; your physician can help you determine whether immunotherapy treatments are right for you.

Targeted Therapies Reach Cancer Cells While Avoiding Healthy Cells

Targeted therapies, sometimes called precision medicine, use drugs to precisely target certain types of cancer cells while avoiding healthy, normal cells. Targeted therapy can be used by itself, or in combination with other treatments like traditional chemotherapy. These therapies work by differentiating between cancer cells and normal cells to block unhealthy cells from dividing and creating new cells. Targeted therapy treatments may also produce fewer side effects than traditional chemotherapy.

Clinical Trials Study New and Effective Ways to Treat Lung Cancer

Lung cancer research is constantly evolving. Clinical trials can provide patients with the opportunity for a better outcome and quality of life while playing a vital role in the development of treatments for lung cancer. SCRI Oncology Partners participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.

Call Us for Information on Lung Cancer Treatments

The lung cancer specialists at SCRI Oncology Partners work with you to create the optimal treatment plan for your lung cancer.